1.Yamashita S, Okita K, Harada K, et al. Giant cavernous hepatic hemangioma shrunk by use of sorafenib. Clin J Gastroenterol, 2013, 6(1): 55–62. DOI: 10.1007/s12328–012–0343–0.
2.Hasan HY, Hinshaw JL, Borman EJ, et al. Assessing normal growth of hepatic hemangiomas during long-term follow-up. JAMA Surg, 2014, 149(12): 1266–71. DOI: 10.1001/jamasurg.2014.477.
3.Miura JT, Amini A, Schmocker R, et al. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford), 2014, 16(10): 924–8. DOI: 10.1111/hpb.12291.
4.Zhang W, Huang ZY, Ke CS, et al. Surgical Treatment of Giant Liver Hemangioma Larger Than 10 cm: A Single Center’s Experience With 86 Patients. Medicine (Baltimore), 2015, 94(34): e1420. DOI: 10.1097/md.0000000000001420.
5.Park SY, Tak WY, Jung MK, et al. Symptomatic-enlarging hepatic hemangiomas are effectively treated by percutaneous ultrasonography-guided radiofrequency ablation. J Hepatol, 2011, 54(3): 559–65. DOI: 10.1016/j.jhep.2010.07.024.
6.Gao J, Ke S, Ding XM, et al. Radiofrequency ablation for large hepatic hemangiomas: initial experience and lessons. Surgery, 2013, 153(1): 78–85. DOI: 10.1016/j.surg.2012.06.004.
7.Gao J, Ji JS, Ding XM, et al. Laparoscopic Radiofrequency Ablation for Large Subcapsular Hepatic Hemangiomas: Technical and Clinical Outcomes. PLoS One, 2016, 11(2): e0149755. DOI: 10.1371/journal.pone.0149755.
8.Gao J, Xu L, Yang MM, et al. A Severe Complication of Myocardial Dysfunction Post Radiofrequency Ablation Treatment of Huge Hepatic Hemangioma: A Case Report and Literature Review. Open Med (Wars), 2019, 14: 398–402. DOI: 10.1515/med–2019–0041.
9.Mendonca R, Silveira AAConran N Red cell DAMPs and inflammation. Inflamm Res, 2016, 65(9): 665–78. DOI: 10.1007/s00011–016–0955–9.
10.Schaer DJ, Buehler PW, Alayash AI, et al. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood, 2013, 121(8): 1276–84. DOI: 10.1182/blood–2012–11–451229.
11.Gouveia Z, Carlos AR, Yuan X, et al. Characterization of plasma labile heme in hemolytic conditions. Febs j, 2017, 284(19): 3278–3301. DOI: 10.1111/febs.14192.
12.Larsen R, Gouveia Z, Soares MP, et al. Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases. Front Pharmacol, 2012, 3: 77. DOI: 10.3389/fphar.2012.00077.
13.Dutra FFBozza MT Heme on innate immunity and inflammation. Front Pharmacol, 2014, 5: 115. DOI: 10.3389/fphar.2014.00115.
14.Belcher JD, Chen C, Nguyen J, et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood, 2014, 123(3): 377–90. DOI: 10.1182/blood–2013–04–495887.
15.Erdei J, Toth A, Balogh E, et al. Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells. 2018, 2018: 4310816. DOI: 10.1155/2018/4310816.
16.Guarda CCD, Santiago RP, Fiuza LM, et al. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia. Expert Rev Hematol, 2017, 10(6): 533–541. DOI: 10.1080/17474086.2017.1327809.
17.Gao J, Fan RF, Yang JY, et al. Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts. World J Gastroenterol, 2017, 23(39): 7077–7086. DOI: 10.3748/wjg.v23.i39.7077.
18.Veerreddy P Hemoglobinuria misidentified as hematuria: review of discolored urine and paroxysmal nocturnal hemoglobinuria. Clin Med Insights Blood Disord, 2013, 6: 7–17. DOI: 10.4137/cmbd.s11517.
19.Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101(6): 1644–55. DOI: 10.1378/chest.101.6.1644.
20.Dong S, Kong J, Kong F, et al. Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways. J Transl Med, 2013, 11: 273. DOI: 10.1186/1479–5876–11–273.
21.Wang S, Gao J, Yang M, et al. Intratumoral coagulation by radiofrequency ablation facilitated the laparoscopic resection of giant hepatic hemangioma: a surgical technique report of two cases. Oncotarget, 2017, 8(31): 52006–52011. DOI: 10.18632/oncotarget.18994.
22.Lee SKDing JL A perspective on the role of extracellular hemoglobin on the innate immune system. DNA Cell Biol, 2013, 32(2): 36–40. DOI: 10.1089/dna.2012.1897.
23.Kato GJ, Steinberg MHGladwin MT Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest, 2017, 127(3): 750–760. DOI: 10.1172/jci89741.
24.Vinchi F, Costa da Silva M, Ingoglia G, et al. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease. Blood, 2016, 127(4): 473–86. DOI: 10.1182/blood–2015–08–663245.